Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)

Denis Poddubnyy, Kay-Geert A Hermann, Johanna Callhoff, Joachim Listing, Joachim Sieper

Source record

Source: Crossref

Published: May 1, 2014

DOI: 10.1136/annrheumdis-2013-204248

Open original source ↗

Evidence graph

No public relationships recorded yet.

Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.